Monere
PrivateLast Round
Accelerator
Sep 22, 2024
Total Funding Raised
$560,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Monere operates in Healthcare & Life Sciences and is based in Lehi, Utah. Its latest recorded funding round was an Accelerator round in September 2024.
Monere is a health technology company that develops a non-invasive, AI-powered platform to screen for and monitor anemia using smartphone-based hemoglobin estimation.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Monere Comparables
Compare Monere with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HemaChrome | 88% | |
| Sanguina, Inc. | 85% | |
| Masimo Corporation | 61% |
For institutional investors. Book with your work email.
Monere Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 22, 2024 | ||||
| Pre Seed | Apr 14, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Monere Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT Solve | Accelerator |
| Altitude Lab | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 30% MoM.
- Sep 22, 2024
$10K round with Altitude Lab and MIT Solve.
For institutional investors. Book with your work email.
Monere Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Monere's valuation, stock price, and market status.
Is Monere a public or private company?
Monere is a private company.
What is the current stock price of Monere?
Monere is a private company, so its shares have no public market price. Caplight tracks Monere's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Monere worth (valuation)?
Valuation information for Monere is not publicly available.
Can I buy Monere stock?
Monere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Monere's last funding round?
Monere's most recent funding round was Accelerator on September 22, 2024.
Who are the main investors in Monere?
Key investors in Monere include MIT Solve, Altitude Lab.
Will Monere IPO soon?
No public IPO plans have been announced for Monere.
How can I track Monere secondary market activity?
Caplight tracks bids, offers, and trades in Monere's shares on secondary markets.